Global Autoinjector Market is currently dominated by many market players. The key players in the market are engaged in new product launches and strategic collaborations to strengthen their market position. For instance, in June 2018, AbbVie, Inc. and Eisai Co., Ltd. launched HUMIRA pen, an autoinjector formulation for fully human anti-TNF- α monoclonal antibody. Global Autoinjectors Market is expected to register a CAGR of 17.42% to reach USD 79,741 Million by 2024. Some of the key players in the global autoinjector market are AbbVie, Inc., Eli Lily and Company, Ypsomed, Amgen, Inc., Becton, Dickinson and Company, Owen Mumford, Consort Medical, Unilife Corporation, SHL Group (Scandinavian Health Limited), Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Antares Pharma, Novartis International AG, and Bayer AG. Avail Sample Copy for this Report Before Puchase: https://www.marketresearchfuture.com/sample_request/6311 The global autoinjector...